Page last updated: 2024-09-02

tadalafil and Carcinoma, Squamous Cell of Head and Neck

tadalafil has been researched along with Carcinoma, Squamous Cell of Head and Neck in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Alnemri, A; Antysheva, Z; Argiris, A; Axelrod, R; Brown, B; Cognetti, DM; Curry, JM; Degryse, S; Gargano, S; Gibson, MK; Harshyne, LA; Johnson, JM; Kim, YJ; Kotlov, N; Kumar, G; Leiby, BE; Linnenbach, AJ; Luginbuhl, AJ; Mahoney, MG; Mannion, K; Martinez-Outschoorn, U; Netterville, J; Rodeck, U; Shimada, A; Shukla, SK; South, AP; Tuluc, M; Zinner, R	1
Borrello, I; Califano, J; De la Fuente, AC; Gomez, C; Nazarian, R; Reis, IM; Sargi, Z; Serafini, P; Vella, JL; Weed, DT	1
Agrawal, N; Blanco, R; Borrello, I; Califano, JA; Fakhry, C; Goodman, S; Gourin, CG; Ha, PK; Khan, Z; Koch, WM; Levine, M; Marur, S; Neuner, G; Noonan, KA; Richmon, JD; Rudraraju, L; Saunders, J; Serafini, P; Tang, M; Wang, H; Weed, DT; Zhang, Z	1
Ben-Jonathan, N; Fox, SR; Mierzwa, ML; Tuttle, TR; Wells, SI	1

Trials

3 trial(s) available for tadalafil and Carcinoma, Squamous Cell of Head and Neck

Article	Year
Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2022, Mar-01, Volume: 28, Issue:5 Topics: Head and Neck Neoplasms; Humans; Neoadjuvant Therapy; Nivolumab; Papillomavirus Infections; Squamous Cell Carcinoma of Head and Neck; Tadalafil; Treatment Outcome; Tumor Microenvironment	2022
Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Jan-01, Volume: 21, Issue:1 Topics: Adult; Aged; Carbolines; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Head and Neck Neoplasms; Humans; Immunity; Male; Middle Aged; Myeloid Cells; Neoplasm Recurrence, Local; Squamous Cell Carcinoma of Head and Neck; T-Lymphocytes, Regulatory; Tadalafil	2015
Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Jan-01, Volume: 21, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Carbolines; Carcinoma, Squamous Cell; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Head and Neck Neoplasms; Humans; Immunity, Cellular; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Squamous Cell Carcinoma of Head and Neck; T-Lymphocytes; Tadalafil	2015

Other Studies

1 other study(ies) available for tadalafil and Carcinoma, Squamous Cell of Head and Neck

Article	Year
The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma. Cancer letters, 2016, Jan-28, Volume: 370, Issue:2 Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Female; Guanylate Cyclase; Head and Neck Neoplasms; Humans; Mice; Phosphodiesterase 5 Inhibitors; Pyrazoles; Pyridines; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Tadalafil	2016

Article

Year

The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma.

Cancer letters, 2016, Jan-28, Volume: 370, Issue:2

Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Female; Guanylate Cyclase; Head and Neck Neoplasms; Humans; Mice; Phosphodiesterase 5 Inhibitors; Pyrazoles; Pyridines; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Tadalafil

2016